Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

OM.US Logo

OM.US - Current Price

$5.57

Company Information

â–Ľ
Company Name
Outset Medical Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US6901451079
CIK: 0001484612
CUSIP: 690145107
Currency: USD
Full Time Employees: 354
Phone: 669 231 8200
Fiscal Year End: December
IPO Date: Sep 15, 2020
Description:

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Address:

3052 Orchard Drive, San Jose, CA, United States, 95134

Directors & Officers

â–Ľ
Name Title Year Born
Ms. Leslie L. Trigg President, CEO & Chairman 1971
Mr. John L. Brottem J.D. General Counsel & Secretary 1974
Ms. Renee M. Gaeta CFO, Principal Financial Officer & Principal Accounting Officer 1981
Mr. Marc Nash Executive Vice President of R&D, Operations & Service 1989
Mr. James S. Mazzola Vice President of Corporate Communications & Investor Relations NA
Amelia Merrill VP of People Operations & Culture NA
Dr. Michael Aragon M.D. Chief Medical Officer NA
Dinamarie Stefani Senior Vice President of Regulatory Affairs & Quality Assurance NA
Ms. Brittni McGill Chief Nursing Officer NA
Mr. Brett Fogg Senior Vice President of R&D & Operations NA

Shares Statistics

â–Ľ
Shares Outstanding: 18.15M
Shares Float: 12.09M
% Insiders: 262.70%
% Institutions: 9,965.30%
Short % Float: 12.37%

Valuation Metrics

â–Ľ
Enterprise Value: $6.66M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

â–Ľ
Market Cap: $82.78M
EBITDA: $-64.67M
Book Value: $7.78
Earnings/Share: $-11.56
Profit Margin: -73.13%
Operating Margin: -53.73%
ROA (TTM): -15.25%
ROE (TTM): -92.33%
Revenue (TTM): $120.07M
Revenue/Share (TTM): $10.40
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 2.70%

Stock Price History

â–Ľ

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

â–Ľ

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

â–Ľ
Date EPS Actual EPS Estimate Difference Surprise %
Sep 30, 2025 -0.69 -0.65 N/A -615.38%
Jun 30, 2025 -0.84 -0.98 N/A 1,428.57%
Mar 31, 2025 -3.24 -0.94 N/A -24,468.09%
Dec 31, 2024 -5.55 -6.19 N/A 1,033.93%
Sep 30, 2024 -5.85 -6.32 N/A 743.67%
Jun 30, 2024 -0.47 -0.45 N/A -444.44%
Mar 31, 2024 -0.57 -0.55 N/A -363.64%
Dec 31, 2023 -0.59 -0.61 N/A 327.87%
Sep 30, 2023 -0.71 -0.67 N/A -597.01%
Jun 30, 2023 -0.90 -0.78 N/A -1,538.46%
Mar 31, 2023 -0.90 -0.74 N/A -2,162.16%
Dec 31, 2022 -0.86 -0.86 N/A 0.00%
Sep 30, 2022 -0.85 -0.81 N/A -493.83%
Jun 30, 2022 -0.92 -0.70 N/A -3,142.86%
Mar 31, 2022 -0.78 -0.72 N/A -833.33%
Dec 31, 2021 -0.87 -0.77 N/A -1,298.70%
Sep 30, 2021 -0.65 -0.73 N/A 1,095.89%
Jun 30, 2021 -0.66 -0.70 N/A 571.43%
Mar 31, 2021 -0.70 -0.81 N/A 1,358.02%
Dec 31, 2020 -0.75 -0.66 N/A -1,363.64%
Sep 30, 2020 -3.31 -3.10 N/A -677.42%
Jun 30, 2020 -0.50 -2.58 N/A 8,062.02%

Balance Sheet (Yearly)

â–Ľ
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $124.01M $N/A $275.80M $248.98M $26.82M
2023-12-31 $68.51M $N/A $313.80M $190.92M $122.89M
2022-12-31 $73.22M $N/A $400.12M $154.13M $245.99M
2021-12-31 $182.35M $N/A $463.46M $89.38M $374.08M
2020-12-31 $294.97M $N/A $403.83M $75.22M $328.61M
2019-12-31 $36.93M $N/A $88.37M $460.55M $-372.19M
2018-12-31 $33.26M $N/A $151.13M $439.08M $-287.95M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
May 15, 2025 N/A N/A N/A N/A N/A N/A
May 15, 2025 N/A N/A N/A N/A N/A N/A
May 15, 2025 N/A N/A N/A N/A N/A N/A
May 15, 2025 N/A N/A N/A N/A N/A N/A
Feb 18, 2025 N/A N/A N/A N/A N/A N/A
Feb 18, 2025 N/A N/A N/A N/A N/A N/A
Feb 18, 2025 N/A N/A N/A N/A N/A N/A
Jan 21, 2025 N/A N/A N/A N/A N/A N/A
Jan 21, 2025 N/A N/A N/A N/A N/A N/A
Jan 21, 2025 N/A N/A N/A N/A N/A N/A
Jan 21, 2025 N/A N/A N/A N/A N/A N/A
Jan 13, 2025 N/A N/A N/A N/A N/A N/A
Jan 13, 2025 N/A N/A N/A N/A N/A N/A
Jan 13, 2025 N/A N/A N/A N/A N/A N/A
Jan 13, 2025 N/A N/A N/A N/A N/A N/A
Jan 07, 2025 N/A N/A N/A N/A N/A N/A
Jan 07, 2025 N/A N/A N/A N/A N/A N/A
Jan 07, 2025 N/A N/A N/A N/A N/A N/A
Jan 07, 2025 N/A N/A N/A N/A N/A N/A
Nov 15, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist